Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 456354, 10 pages
http://dx.doi.org/10.1155/2015/456354
Research Article

Experimental Study of Antiatherosclerosis Effects with Hederagenin in Rats

1Medical School, Jinan University, 601 Huangpu Road West, Guangzhou, Guangdong 510632, China
2The First Affiliated Hospital of Jinan University, 613 Huangpu Road West, Guangzhou, Guangdong 510632, China

Received 7 January 2015; Accepted 6 April 2015

Academic Editor: Zhang Tan

Copyright © 2015 Su-Hong Lu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. X. Li, C. J. Li, and H. Y. Tan, “Atorvastatin calcium induced liver damage,” Chinese Journal of Misdiagnosis, vol. 11, no. 34, p. 8461, 2011. View at Google Scholar
  2. F. F. Sun, X. Q. Tan, and L. J. Guo, “Atorvastatin calcium induced abnormal liver function,” Journal of Pharmacoepidemiology, vol. 20, no. 5, article 267, 2011. View at Google Scholar
  3. G. Li, “Atorvastatin calcium induced abnormal liver function,” Adverse Drug Reactions Journal, vol. 9, no. 3, p. 181, 2007. View at Google Scholar
  4. B. F. Liang, H. B. Guo, and X. Yuan, “Evaluation of hederagenin antidepressant efficacy,” Chinese Journal of Pharmacology and Toxicology, vol. 26, no. 3, pp. 447–448, 2012. View at Google Scholar
  5. J. Wang, X. Z. Zhao, Q. Qi et al., “Macranthoside B, a hederagenin saponin extracted from Lonicera macranthoides and its anti-tumor activities in vitro and in vivo,” Food and Chemical Toxicology, vol. 47, no. 7, pp. 1716–1721, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Yamahara, Y. Takagi, T. Sawada et al., “Effects of crude drugs on congestive edema,” Chemical and Pharmaceutical Bulletin, vol. 27, no. 6, pp. 1464–1468, 1979. View at Publisher · View at Google Scholar · View at Scopus
  7. H.-M. Ma and B.-L. Zhang, “Comparison among families of Mutong,” China Journal of Chinese Materia Medica, vol. 27, no. 6, pp. 412–418, 2002. View at Google Scholar · View at Scopus
  8. I. Gülçin, V. Mshvildadze, A. Gepdiremen, and R. Elias, “The antioxidant activity of a triterpenoid glycoside isolated from the berries of Hedera colchica: 3-O-(β-D-glucopyranosyl)-hederagenin,” Phytotherapy Research, vol. 20, no. 2, pp. 130–134, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Jiang, Q. P. Gao, S. P. Shi, and P. F. Tu, “Triterpenoid saponins from the fruits of Akebiae quinata,” Chemical and Pharmaceutical Bulletin, vol. 54, no. 5, pp. 595–597, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. M. W. Lee, S. U. Kim, and D.-R. Hahn, “Antifungal activity of modified hederagenin glycosides from the leaves of Kalopanax pictum var. chinense,” Biological and Pharmaceutical Bulletin, vol. 24, no. 6, pp. 718–719, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Choi, Y. N. Han, K.-T. Lee et al., “Anti-lipid peroxidative principles from the stem bark of Kalopanax pictus Nakai,” Archives of Pharmacal Research, vol. 24, no. 6, pp. 536–540, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. L. J. Jing, Y. L. Yong, E. H. Jung, S. Lee, M. K. Jeong, and S. Y.-C. Hye, “Anti-platelet pentacyclic triterpenoids from leaves of Campsis grandiflora,” Archives of Pharmacal Research, vol. 27, no. 4, pp. 376–380, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Quan and M.-Z. Qian, “Effect and mechanism of gypenosides on the inflammatory molecular expression in high-fat induced atherosclerosis rats,” Chinese Journal of Integrative Medicine, vol. 30, no. 4, pp. 403–406, 2010. View at Google Scholar · View at Scopus
  14. J. Pang, Q. Xu, X. Xu et al., “Hexarelin suppresses high lipid diet and vitamin D3-induced atherosclerosis in the rat,” Peptides, vol. 31, no. 4, pp. 630–638, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. X. L. Yang, X. X. Zhao, F. Wang et al., “A new modeling of atherosclerostic in rats,” Journal of Ningxia Medical College, vol. 29, no. 4, pp. 879–882, 2007. View at Google Scholar
  16. P. Y. Yang, Y. C. Rui, and Y. B. Jiao, “Establishment of experimental atherosclerosis model in rats,” Academic Journal of Second Military Medical University, vol. 24, no. 7, pp. 802–804, 2003. View at Google Scholar
  17. S. Y. Xu, R. L. Bian, and X. Chen, Methodology of Pharmacological Experiment, People's Medical Publishing House, Beijing, China, 3rd edition, 2002.
  18. H. Zhou, X. X. Wu, Y. B. Yuan et al., “Comparison of methods for establishing a rat model of atherosclerosis using three-doses of vitamin D3 and atherogenic diet,” Chinese Journal of Arteriosclerosis, vol. 20, no. 11, pp. 995–998, 2012. View at Google Scholar
  19. H. Motoshima, B. J. Goldstein, M. Igata, and E. Araki, “AMPK and cell proliferation-AMPK as a therapeutic target for atherosclerosis and cancer,” Journal of Physiology, vol. 574, no. 1, pp. 63–71, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. P. P. Toth, “High-density lipoprotein as a therapeutic target: clinical evidence and treatment strategies,” The American Journal of Cardiology, vol. 96, no. 9, supplement 1, pp. 50–58, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. G. C. Fonarow, “Treating to goal: new strategies for initiating and optimizing lipid-lowering therapy in patients with atherosclerosis,” Vascular Medicine, vol. 7, no. 3, pp. 187–194, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Sun, “NO pathway and atherosclerosis,” Journal of Chengdu Medical College, vol. 2, no. 1, p. 71, 2007. View at Google Scholar
  23. J. W. Li, “Research progress of vascular endothelial contraction and relaxation factor,” Chinese Journal of Extracorporeal Circulation, vol. 2, no. 1, p. 61, 2004. View at Google Scholar
  24. J. Li and F. Y. Liu, “The change of vasomotor function in atherosclerosis,” Chinese Journal of Cardiovascular Rehabilitation Medicine, vol. 18, no. 5, p. 501, 2009. View at Google Scholar
  25. K. Mujynya-Ludunge, H. Viswambharan, R. Driscoll et al., “Endothelial nitric oxide synthase gene transfer restores endothelium-dependent relaxations and attenuates lesion formation in carotid arteries in apolipoprotein E-deficient mice,” Basic Research in Cardiology, vol. 100, no. 2, pp. 102–111, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. E. Gkaliagkousi and A. Ferro, “Nitric oxide signalling in the regulation of cardiovascular and platelet function,” Frontiers in Bioscience, vol. 16, no. 5, pp. 1873–1897, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. V. Zancan, S. Santagati, C. Bolego, E. Vegeto, A. Maggi, and L. Puglisi, “17β-estradiol decreases nitric oxide synthase II synthesis in vascular smooth muscle cells,” Endocrinology, vol. 140, no. 5, pp. 2004–2009, 1999. View at Google Scholar · View at Scopus
  28. W. Y. Z. Di and Y. Y. Yan, “Effects of Rou Tong Decoction on plasma ET-1 and serum NO content in experimental atherosclerosis rabbits,” Modern Traditional Chinese Medicine, vol. 25, no. 6, article 12, 2005. View at Google Scholar
  29. S. L. Bourque, S. T. Davidge, and M. A. Adams, “The interaction between endothelin-1 and nitric oxide in the vasculature: new perspectives,” The American Journal of Physiology—Regulatory, Integrative and Comparative Physiology, vol. 300, no. 6, pp. R1288–R1295, 2011. View at Publisher · View at Google Scholar
  30. R. Ross, “Atherosclerosis—an inflammatory disease,” The New England Journal of Medicine, vol. 340, no. 2, pp. 115–126, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Libby, “Inflammation in atherosclerosis,” Nature, vol. 420, no. 6917, pp. 868–874, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. H. X. Xu, J. J. Li, and G. S. Li, “Nuclear factor kappa B and atherosclerosis,” Chinese Journal of Arteriosclerosis, vol. 9, no. 2, pp. 179–181, 2001. View at Google Scholar
  33. J. Mestas and K. Ley, “Monocyte-endothelial cell interactions in the development of atherosclerosis,” Trends in Cardiovascular Medicine, vol. 18, no. 6, pp. 228–232, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. B. C. H. Lutters, M. A. Leeuwenburgh, C. C. M. Appeldoorn, T. J. M. Molenaar, T. J. C. van Berkel, and E. A. L. Biessen, “Blocking endothelial adhesion molecules: a potential therapeutic strategy to combat atherogenesis,” Current Opinion in Lipidology, vol. 15, no. 5, pp. 545–552, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. V. Benson, A. C. McMahon, and H. C. Lowe, “ICAM-1 in acute myocardial infarction: a potential therapeutic target,” Current Molecular Medicine, vol. 7, no. 2, pp. 219–227, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. S.-R. Kim, Y.-H. Bae, S.-K. Bae et al., “Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-κB activation in endothelial cells,” Biochimica et Biophysica Acta: Molecular Cell Research, vol. 1783, no. 5, pp. 886–895, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. A. R. Brasier, “The nuclear factor-B-interleukin-6 signalling pathway mediating vascular inflammation,” Cardiovascular Research, vol. 86, no. 2, pp. 211–218, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. N. Li and M. Karin, “Ionizing radiation and short wavelength UV activate NF-κB through two distinct mechanisms,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 22, pp. 13012–13017, 1998. View at Publisher · View at Google Scholar · View at Scopus
  39. A. H. Wagner, M. Gebauer, B. Pollok-Kopp, and M. Hecker, “Cytokine-inducible CD40 expression in human endothelial cells is mediated by interferon regulatory factor-1,” Blood, vol. 99, no. 2, pp. 520–525, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Gallmeier, C. Schäfer, P. Moubarak et al., “JAK and STAT proteins are expressed and activated by IFN-γ in rat pancreatic acinar cells,” Journal of Cellular Physiology, vol. 203, no. 1, pp. 209–216, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Agrawal, M. Febbraio, E. Podrez, M. K. Cathcart, G. R. Stark, and G. M. Chisolm, “Signal transducer and activator of transcription 1 is required for optimal foam cell formation and atherosclerotic lesion development,” Circulation, vol. 115, no. 23, pp. 2939–2947, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Horiuchi, W. Hayashida, M. Akishita et al., “Interferon-γ induces AT2 receptor expression in fibroblasts by Jak/STAT pathway and interferon regulatory factor-1,” Circulation Research, vol. 86, no. 2, pp. 233–240, 2000. View at Publisher · View at Google Scholar · View at Scopus
  43. N. Li and M. Karin, “Ionizing radiation and short wavelength UV activate NF-κB through two distinct mechanisms,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 22, pp. 13012–13017, 1998. View at Publisher · View at Google Scholar · View at Scopus